 "Gujarat Kidney and Super Speciality IPO subscribed 5.2 times on final day")
The initial public offering (IPO) of Gujarat Kidney and Super Speciality was subscribed 5.21 times on the final day of its issue on Wednesday. The retail and non-institutional portions were subscribed to 19.04 and 5.73, respectively. The quota for qualified institutional investors was subscribed 1.06 times.
The ₹251 crore IPO was priced between ₹108 and ₹114 per share. The IPO was entirely a fresh issue, and the company plans to utilise the proceeds for proposed acquisitions, part payment of purchase consideration for an already acquired hospital, acquisition of additional shareholding in a subsidiary, capital expenditure requirements, and debt repayment.
The company operates a chain of mid-sized multispecialty hospitals with a total operational bed capacity of 340. 2025 has been a blockbuster year for IPOs, with 103 companies listing, the most in 25 years. This also marks the first time India has seen two consecutive years of record primary-market fundraising; historically, a blockbuster year has been followed by two to three quieter ones.
The boom comes despite a volatile backdrop for secondary markets. Corporate profit softness and uncertainty around the trade deal with the US have weighed on markets this year. Yet the IPO market has remained resilient.